Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 22-Apr-24 4:00 PM View:  | Cormorant Asset Management,... 10% Owner | Eyepoint Pharmaceuticals, I... (EYPT) | 18-Apr-24 | Purchase | 581,765 | $18.03 | $10,489,400.00 | 8% 6.89M to 7.47M | |
| 02-Apr-24 5:27 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Mar-24 | Payment of Exercise | 25,546 | $20.67 | $528,036.00 | (28%) 92.63K to 67.08K | |
| 02-Apr-24 5:27 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 30-Mar-24 | Option Exercise | 50,404 | -- | -- | 119% 42.22K to 92.63K | |
| 28-Feb-24 4:46 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Feb-24 | Gift | 2,500 | -- | -- | 5% 51.92K to 54.42K | |
| 28-Feb-24 4:46 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 27-Feb-24 | Gift | 2,500 | -- | -- | (5%) 54.42K to 51.92K | |
| 22-Feb-24 5:08 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 20-Feb-24 | Gift | 20,000 | -- | -- | 39% 51.92K to 71.92K | |
| 22-Feb-24 5:08 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 20-Feb-24 | Gift | 20,000 | -- | -- | (28%) 71.92K to 51.92K | |
| 13-Feb-24 5:40 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Feb-24 | Gift | 74,681 | -- | -- | (26%) 284.92K to 210.24K | |
| 13-Feb-24 5:40 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 13-Feb-24 | Gift | 74,681 | -- | -- | 36% 210.24K to 284.92K | |
| 13-Feb-24 5:39 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 5,083 | $28.80 | $146,390.00 | (11%) 47.3K to 42.22K | |
| 13-Feb-24 5:38 PM View: | Elston George Chief Financial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 10,800 | -- | -- | 30% 36.0K to 46.8K | |
| 13-Feb-24 5:37 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 3,533 | $28.80 | $101,750.00 | (6%) 55.45K to 51.92K | |
| 13-Feb-24 5:38 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 9,967 | -- | -- | 26% 38.6K to 48.57K | |
| 13-Feb-24 5:40 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 14,943 | $28.80 | $430,358.00 | (7%) 225.18K to 210.24K | |
| 13-Feb-24 5:40 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 37,534 | -- | -- | 20% 187.65K to 225.18K | |
| 13-Feb-24 5:38 PM View: | Elston George Chief Financial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 3,192 | $28.80 | $91,929.60 | (7%) 46.8K to 43.61K | |
| 13-Feb-24 5:39 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 10,800 | -- | -- | 30% 36.51K to 47.3K | |
| 13-Feb-24 5:38 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Payment of Exercise | 3,656 | $28.80 | $105,293.00 | (8%) 48.57K to 44.92K | |
| 13-Feb-24 5:37 PM View: | Duker Jay S. President and CEO Director | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Feb-24 | Option Exercise | 11,967 | -- | -- | 28% 43.49K to 55.45K | |
| 05-Feb-24 5:15 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 02-Feb-24 | Option Sale | 209 | $28.49 | $5,954.41 | (< 1%) 38.17K to 37.96K | |
| 05-Feb-24 5:15 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 02-Feb-24 | Option Exercise | 209 | $11.47 | $2,397.23 | < 1% 37.96K to 38.17K | |
| 29-Jan-24 5:54 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Option Sale | 26,017 | $25.38 | $660,370.00 | (41%) 63.98K to 37.96K | |
| 30-Jan-24 4:53 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Private Option Sale | 49,325 | $25.66 | $1,265,540.00 | (57%) 85.83K to 36.51K | |
| 30-Jan-24 4:53 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Option Exercise | 49,325 | $13.06 | $644,047.00 | 135% 36.51K to 85.83K | (3%) |
| 29-Jan-24 5:54 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 26-Jan-24 | Option Exercise | 26,017 | $6.82 | $177,398.00 | 69% 37.96K to 63.98K | |
| 29-Jan-24 5:51 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Option Exercise | 600 | $13.02 | $7,809.00 | 2% 36.51K to 37.1K | (3%) |
| 26-Jan-24 5:03 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Option Exercise | 600 | $8.08 | $4,848.00 | 2% 37.96K to 38.56K | |
| 26-Jan-24 5:03 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Option Sale | 600 | $25.00 | $15,000.00 | (2%) 38.56K to 37.96K | |
| 29-Jan-24 5:51 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 25-Jan-24 | Private Option Sale | 600 | $25.00 | $15,000.00 | (2%) 37.1K to 36.51K | |
| 25-Jan-24 6:24 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Sale | 29,956 | $24.98 | $748,250.00 | (14%) 217.6K to 187.65K | |
| 26-Jan-24 5:03 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Sale | 11,300 | $25.01 | $282,621.00 | (23%) 49.26K to 37.96K | |
| 25-Jan-24 6:26 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Sale | 11,251 | $25.01 | $281,415.00 | (24%) 47.76K to 36.51K | |
| 25-Jan-24 6:26 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Exercise | 11,251 | $13.01 | $146,426.00 | 31% 36.51K to 47.76K | |
| 26-Jan-24 5:03 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 24-Jan-24 | Option Exercise | 11,300 | $8.04 | $90,822.00 | 30% 37.96K to 49.26K | |
| 24-Jan-24 4:50 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Option Sale | 900 | $25.00 | $22,500.00 | (2%) 38.86K to 37.96K | |
| 25-Jan-24 6:26 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Private Option Sale | 5,135 | $25.00 | $128,375.00 | (12%) 41.64K to 36.51K | |
| 25-Jan-24 6:26 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Option Exercise | 5,135 | $13.04 | $66,953.60 | 14% 36.51K to 41.64K | (3%) |
| 24-Jan-24 4:50 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Option Exercise | 900 | $7.54 | $6,790.00 | 2% 37.96K to 38.86K | |
| 25-Jan-24 6:24 PM View: | Lurker Nancy Executive Vice Chair Director | Eyepoint Pharmaceuticals, I... (EYPT) | 23-Jan-24 | Private Sale | 5,044 | $24.97 | $125,950.00 | (2%) 222.65K to 217.6K | |
| 24-Jan-24 4:50 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 22-Jan-24 | Option Exercise | 34,166 | $10.34 | $353,359.00 | 90% 37.96K to 72.13K | |
| 24-Jan-24 4:50 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 22-Jan-24 | Option Sale | 34,166 | $22.62 | $772,691.00 | (47%) 72.13K to 37.96K | |
| 16-Jan-24 6:01 PM View: | Liu Ye Director | Eyepoint Pharmaceuticals, I... (EYPT) | 11-Jan-24 | Private Sale Duplicate | 1,910,500 | $19.45 | $37,159,200.00 | (95%) 2.01M to 100.22K | |
| 11-Jan-24 4:00 PM View: | Cormorant Asset Management,... 10% Owner | Eyepoint Pharmaceuticals, I... (EYPT) | 11-Jan-24 | Purchase | 750,000 | $19.75 | $14,812,500.00 | 12% 6.14M to 6.89M | |
| 16-Jan-24 6:55 PM View: | Ocumension Therapeutics Director | Eyepoint Pharmaceuticals, I... (EYPT) | 11-Jan-24 | Private Sale | 1,910,500 | $19.45 | $37,159,200.00 | (95%) 2.01M to 100.22K | |
| 11-Jan-24 4:00 PM View: | Cormorant Asset Management,... 10% Owner | Eyepoint Pharmaceuticals, I... (EYPT) | 09-Jan-24 | Purchase | 105,000 | $21.32 | $2,238,600.00 | 2% 6.04M to 6.14M | |
| 10-Jan-24 4:53 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 08-Jan-24 | Option Exercise | 22,913 | $3.26 | $74,696.40 | 63% 36.51K to 59.42K | |
| 10-Jan-24 4:53 PM View: | Paggiarino Dario A. Chief Medical Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 08-Jan-24 | Option Sale | 22,913 | $21.13 | $484,124.00 | (39%) 59.42K to 36.51K | |
| 09-Jan-24 9:11 PM View: | Pine Michael Craig Chief Corp Dev.&Strat. Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Option Exercise | 15,285 | -- | -- | 352% 4.34K to 19.63K | |
| 09-Jan-24 9:04 PM View: | Elston George Chief Financial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Payment of Exercise | 4,911 | $20.40 | $100,184.00 | (12%) 40.22K to 35.31K | |
| 09-Jan-24 9:09 PM View: | Jones David Scott SVP & Chief Commercial Officer | Eyepoint Pharmaceuticals, I... (EYPT) | 06-Jan-24 | Payment of Exercise | 4,147 | $20.40 | $84,598.80 | (10%) 42.11K to 37.96K |
